JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY is a distinguished publication presented by the POLISH PHYSIOLOGICAL SOC, dedicated to advancing the fields of physiology and pharmacology. Since its inception in 1991, this journal has maintained a commitment to disseminating vital research findings, contributing to the growing body of knowledge essential for understanding complex biological systems and their interactions with pharmacological agents. With a consistent focus on interdisciplinary studies, the journal holds a Q3 categorization in both Medicine and Pharmacology as well as Physiology for 2023, reflecting its relevance in these crucial fields. Although specific access options are not available, the journal's robust indexing and rankings in Scopus signify its credibility and the high caliber of its contributions, appealing to researchers, professionals, and students alike. Operating from the picturesque Jagiellonian University in Krakow, Poland, this journal not only enriches the academic landscape but also fosters global collaboration and innovation in the life sciences.

CHINESE JOURNAL OF PHYSIOLOGY, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, has been a vital resource since its inception in 1971, catering to the expansive field of physiology. Operating out of Taiwan, this journal addresses critical research in both general and medical physiology, providing a platform for innovative studies that contribute significantly to the understanding of biological processes. With an emphasis on disseminating high-quality, peer-reviewed articles, it holds a Q4 ranking in Physiology and a Q3 ranking in Medical Physiology as of 2023, reflecting its commitment to advancing physiological science. The ISSN for this journal is 0304-4920 and the E-ISSN is 2666-0059. While access options are not available as open access, researchers and professionals can still benefit from its valuable insights. Notably, it ranks #78/113 in Medicine - Physiology and #159/193 in Biochemistry, Genetics, and Molecular Biology - Physiology on Scopus, indicating its growing influence in the scientific community. We invite researchers, professionals, and students alike to explore the wealth of knowledge featured within the pages of the CHINESE JOURNAL OF PHYSIOLOGY.

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

Animal Cells and Systems, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal that has been disseminating high-quality research since 2017. With an ISSN of 1976-8354 and an E-ISSN of 2151-2485, this journal is dedicated to advancing the understanding of animal cellular biology and the intricate systems that govern organismal functions. Recognized for its rigorous peer-review process, it holds an esteemed position in the academic community, boasting a Q1 ranking in Animal Science and Zoology and a Q2 ranking in Biochemistry, Genetics and Molecular Biology for 2023. The journal is indexed in Scopus, ranked #79/490 in Animal Science and Zoology and #85/221 in General Biochemistry, Genetics, and Molecular Biology, affirming its impact and relevance in these fields. With a commitment to providing researchers, professionals, and students with vital insights and cutting-edge research, Animal Cells and Systems is an essential resource for those looking to explore the complex landscapes of animal biology.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

The Journal of Physiological Sciences, published by BMC, stands as a prominent platform for the advancement of research in the field of physiology. Based in Japan, this open-access journal (ISSN: 1880-6546, E-ISSN: 1880-6562) is committed to disseminating high-quality scientific articles that explore various facets of physiological functions and mechanisms. With a 2023 Scopus ranking placing it within the 41st percentile in the category of Physiology, it is recognized for contributing significant insights that bridge basic and applied physiological research. The journal maintains a Q2 quartile ranking within its category, highlighting its impact within the scientific community. Researchers, professionals, and students are encouraged to engage with cutting-edge studies published from 2006 to 2024, fostering an environment of knowledge accessibility and scientific collaboration. The journal not only serves as a vital resource for those involved in physiological research but also promotes broader understanding and application of physiological principles across various health and science sectors.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, published by Elsevier Science Ltd, is a premier scholarly journal dedicated to advancing the field of cardiology and cardiovascular medicine as well as molecular biology. With an impressive Q1 ranking in both categories as of 2023, the journal boasts a significant influence in the scientific community, evidenced by its Scopus rankings—33rd out of 387 in Cardiology and 65th out of 410 in Molecular Biology. Established in 1970 and continuing to publish groundbreaking research through 2024, the journal’s mission is to disseminate innovative findings that enhance our understanding of cardiovascular health at the molecular and cellular levels. Although it is not an open-access publication, it attracts top-tier research contributions, making it essential reading for researchers, healthcare professionals, and students aiming to stay ahead in the dynamic domains of cardiovascular and molecular biology research.

Discovery Medicine, an esteemed journal published by Discovery Medicine, serves as a vital platform within the field of general medicine, dedicated to advancing knowledge through high-quality research and innovative insights. With its ISSN 1539-6509 and E-ISSN 1944-7930, this journal boasts an impressive Scopus ranking of #29 out of 529 in the general medicine category, positioning it at the 94th percentile, indicating its significant contribution to the medical sciences. While operating as a subscription-based journal, Discovery Medicine fosters an environment where researchers and professionals can disseminate their findings and engage with cutting-edge developments in medicine. Spanning topics that bridge clinical practice and healthcare advancements, this journal aims to inform, challenge, and inspire the medical community. The journal has converged its volumes from 2006 to 2007 and again from 2009 to 2018, highlighting its sustained commitment to excellence even as coverage has temporarily discontinued in Scopus. Situated at 10 Gerard Ave, Ste 201, Timonium, MD 21093, Discovery Medicine continues to be a cornerstone for medical scholars, offering a rich repository of knowledge essential for ongoing research and practical applications.

CELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.